13G Filing: Perceptive Advisors and Ocera Therapeutics Inc. (OCRX)

Page 8 of 8

Page 8 of 8 – SEC Filing

CUSIP
No. 67552A108
13G Page
8 of 8 Pages

SIGNATURE

 

After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.

 

 

April 17, 2017

  Date
   
  PERCEPTIVE ADVISORS LLC
   
  /s/
Joseph Edelman
  Signature
   
  Joseph
Edelman/Managing Member
  Name/Title
   
 

April 17, 2017

  Date
   
 

PERCEPTIVE
LIFE SCIENCES MASTER FUND LTD

   
 

/s/
Joseph Edelman

  Signature
   
 

Joseph Edelman/Managing
Member

   
 

April 17, 2017

  Date
   
  /s/
Joseph Edelman
  Signature
   
  Joseph
Edelman
  Name/Title

 

The original
statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement
is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing
person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided,
however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference.
The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

 

NOTE:
Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See
§240.13d-7 for other parties for whom copies are to be sent.

 

Attention: Intentional misstatements
or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)

Follow Ocera Therapeutics Inc. (NASDAQ:OCRX)

Page 8 of 8